Travere Therapeutics Inc
TVTX
Get informed when a big investor buys or sells
+ FollowMarket Cap$4.72B
Close$
Share Statistics
| Market cap | $4.72 Billion |
|---|---|
| Enterprise Value | $5.22 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.56 |
| Beta | 1.14 |
| Outstanding Shares | 93,479,416 |
Return
| Return on Equity | -270.52% |
|---|---|
| Return on Assets | -8.30% |
| Return on Invested Capital | -10.32% |
Valuation & Multiples
| P/E Ratio | -111.29 |
|---|---|
| PEG | -64.4 |
| Price to Sales | 8.35 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 8.83 |
| Enterprise Value to EBIT | -78.1 |
| Enterprise Value to Net Income | -79 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | 25.16 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 5, 2026
EPS Estimate
$-0.14
Average shareholder expectationRevenue Estimate
$159.59 M
Average shareholder expectationNext Earnings Call
Expected Date
October 29, 2026
EPS Estimate
$-0.04
Average shareholder expectationRevenue Estimate
$198.32 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 61.45% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 1.60%▼ 111.91% |
|---|---|
| Total Invested | $88.03M▼ 98.54% |
| Investors Holding | 19▼ 313.00% |
ESG Score
No data